Skip to content
Est. 1998 proudly celebrating our 27th year of championing American business
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

HeartSciences Inc.

  • SOUTHLAKE, Texas
  • Public · NASDAQ: HSCS
  • 12 employees
$6.2MMarket cap
$4.3KRevenue · FY2025
-$8.8MNet income
12Employees
HSCSNASDAQ
2022IPO

About HeartSciences Inc.

HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2025
$4.3K
Net income
-$8.8M
Total assets
$4.2M
Market cap
$6.2M

Source: SEC EDGAR · updated Jun 8, 2026

NASDAQ: HSCS

15-minute delayed · data by Polygon.io

Market cap
$6.2M
Open
Day range
Prev close
Volume
IPO date
Jun 15, 2022

Market data by Polygon.io · prices are 15-minute delayed

No reviews yet. Be the first to review HeartSciences Inc..

Write a review
Explore

Similar companies

Browse all →